维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="Andrew GP"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Mucoadhesive polymeric platforms for controlled drug delivery显示文摘	Andrews GP Laverty TP Jones DS	2009	Eur J Pharm Biopharm2009，71，3：	1
2	Defieit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia 显示文摘	Reynolds GP Czudek C Andrews HB	1990	Biol Psychiatr1990，27，：	1
3	Mucoadhesive polymeric platforms for controlled drug detivery 显示文摘	Andrews GP Laverty TP Jones DS	2009	Eur J Pharm Biopharm2009，71，：	1
4	Improved outcomes in patients with osteogenic sarcoma of the head and neck 显示文摘	Snehal GP Paul M Andrew GH	2002	Cancer2002，95，7：	1
5	Immune response to Yersinia outer proteins and other Yersinia pestis antigens after ex- perimental plague infection in mice 显示文摘	Benner GE Andrews GP Byrne WR	1999	Infect Immun1999，67，4：	1
6	The manufacture and characterization of hot-melt extruded enteric tablets显示文摘	Andrews GP Jones DS Diak OA	2008	Eur J Pharm Biopharm2008，69，1：	1
7	Immune response to Yersinia outer proteins and other Yersinia pestis antigens aher experimental plague infection in mice 显示文摘	Benner GE Andrews GP Byme WR	1999	Infect Immun1999，67，4：	1
8	Protective efficicy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis 显示文摘	Andrews GP Strachan ST Benner GE ET AL	1999	Infect Immun1999，67，3：	1
9	Global carbon budget 2014 显示文摘	Ire Quere C Moriarty R Andrew RM Peters GP Ciais P Frie- dlingstein P	2015	Earth System Science Data2015，7，1：	1
10	Fraction 1 capsular antigen(F1 ) purification form Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge 显示文摘	Andrews GP Heath DG Anderson GW	1996	Infect Immun1996，64，6：	1
11	Improved outcomes in patients with osteogenic sarcoma of the head and neck 显示文摘	Snehal GP Paul M Andrew GH	2002	Cancer2002，95，7：	1
12	Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague 显示文摘	Powell BS Andrews GP Enama JT	2005	Biotechnol Prog2005，21，5：	1
13	Design and testing for a non tagged F1-V fusion protein as vaccine an tigen against bubonic and pneumonic plague 显示文摘	Powel! BS Andrews GP Enama JT	2005	Biotechnol Prog2005，21，5：	1
14	Understanding the per-formance of melt-extruded poly (ethylene oxide)-bicalutamide solid dispersions: characterisation of microstructural properties using thermal, spectroscopic and drug release methods显示文摘	Abu-Diak OA Jones DS Andrews GP	2012	J Pharm Sci2012，101，1：	1
15	Uterine fibroid embolization: technical aspects 显示文摘	Worthington-Kitsch RL Andrews RT Siskin GP	2002	Tech Vasc Interv Radiol2002，5，1：	1
16	Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice显示文摘	Benner GE Andrews GP Byrne GP	1999	Infect Immun1999，67，4：	1
17	An investigation into the dissolution properties of celecoxib melt extrudates: understanding the role of polymer type and concentration in stabilizing supersaturated drug concentrations显示文摘	Abu-Diak OA Jones DS Andrews GP	2011	Mol Pharm2011，8，4：	1
18	Fraction 1capsular antigen(F1) purification from Yersinia pestis CO92and an Escherichia coli recombinant strain and efficacy against lethal plague challenge 显示文摘	Heath DG Anderson GW	1996	Infect Immun1996，64，6：	1
19	Fraction 1 capsular antigen ( F1 ) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge 显示文摘	Andrews GP Heath DG Anderson GW	1996	Infect Immun1996，6，：	1
20	The manufacture and charac- terization of hot-melt extruded entruded enteric tables显示文摘	Andrews GP Jones DS Diak OA	2008	Eur J Pharm Biopharm2008，69，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示